시장조사 보고서 : 세계의 신경 장애성 통증 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02241 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 신경 장애성 통증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (칼슘 채널 알파 2-델타 리간드, 세로토닌-노르에피네프린 재흡수 억제제, 기타)와 용도별 시장규모 (소매 약국, 병원, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 신경 장애성 통증 치료 시장 점유율
- 지역별 신경 장애성 통증 치료 시장규모
- 주요지역의 종류별 시장규모 (칼슘 채널 알파 2-델타 리간드, 세로토닌-노르에피네프린 재흡수 억제제, 기타)
- 주요지역의 용도별 시장규모 (소매 약국, 병원, 기타)
- 미주의 신경 장애성 통증 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 신경 장애성 통증 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 신경 장애성 통증 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 신경 장애성 통증 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 신경 장애성 통증 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Pfizer, Depomed, Eli Lilly, Endo, Grünenthal Group, Arbor Pharmaceuticals
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Neuropathy Pain Treatment will have significant change from previous year. By the most conservative estimates of global Neuropathy Pain Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 8078.4 million in 2020. Over the next five years the Neuropathy Pain Treatment market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 9242.7 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuropathy Pain Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Calcium Channel Alpha 2-delta Ligands
Serotonin-norepinephrine Reuptake Inhibitors
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Retail Pharmacies
Hospitals
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Depomed
Eli Lilly
Endo
Grünenthal Group
Arbor Pharmaceuticals

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuropathy Pain Treatment Market Size 2016-2026
2.1.2 Neuropathy Pain Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Neuropathy Pain Treatment Segment by Type
2.2.1 Calcium Channel Alpha 2-delta Ligands
2.2.2 Calcium Channel Alpha 2-delta Ligands
2.2.3 Others
2.3 Neuropathy Pain Treatment Market Size by Type
2.3.1 Global Neuropathy Pain Treatment Market Size CAGR by Type
2.3.2 Global Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
2.4 Neuropathy Pain Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospitals
2.4.3 Others
2.5 Neuropathy Pain Treatment Market Size by Application
2.5.1 Global Neuropathy Pain Treatment Market Size CAGR by Application
2.5.2 Global Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)

3 Neuropathy Pain Treatment Market Size by Players
3.1 Neuropathy Pain Treatment Market Size Market Share by Players
3.1.1 Global Neuropathy Pain Treatment Revenue by Players (2019-2021E)
3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Neuropathy Pain Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Neuropathy Pain Treatment by Regions
4.1 Neuropathy Pain Treatment Market Size by Regions (2016-2021)
4.2 Americas Neuropathy Pain Treatment Market Size Growth (2016-2021)
4.3 APAC Neuropathy Pain Treatment Market Size Growth (2016-2021)
4.4 Europe Neuropathy Pain Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Neuropathy Pain Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Neuropathy Pain Treatment Market Size by Country (2016-2021)
5.2 Americas Neuropathy Pain Treatment Market Size by Type (2016-2021)
5.3 Americas Neuropathy Pain Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Neuropathy Pain Treatment Market Size by Region (2016-2021)
6.2 APAC Neuropathy Pain Treatment Market Size by Type (2016-2021)
6.3 APAC Neuropathy Pain Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Neuropathy Pain Treatment by Country (2016-2021)
7.2 Europe Neuropathy Pain Treatment Market Size by Type (2016-2021)
7.3 Europe Neuropathy Pain Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Neuropathy Pain Treatment by Region (2016-2021)
8.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Neuropathy Pain Treatment Market Forecast
10.1 Global Neuropathy Pain Treatment Forecast by Regions (2021-2026)
10.1.1 Global Neuropathy Pain Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Neuropathy Pain Treatment Forecast
10.1.3 APAC Neuropathy Pain Treatment Forecast
10.1.4 Europe Neuropathy Pain Treatment Forecast
10.1.5 Middle East & Africa Neuropathy Pain Treatment Forecast
10.2 Americas Neuropathy Pain Treatment Forecast by Countries (2021-2026)
10.2.1 United States Neuropathy Pain Treatment Market Forecast
10.2.2 Canada Neuropathy Pain Treatment Market Forecast
10.2.3 Mexico Neuropathy Pain Treatment Market Forecast
10.2.4 Brazil Neuropathy Pain Treatment Market Forecast
10.3 APAC Neuropathy Pain Treatment Forecast by Region (2021-2026)
10.3.1 China Neuropathy Pain Treatment Market Forecast
10.3.2 Japan Neuropathy Pain Treatment Market Forecast
10.3.3 Korea Neuropathy Pain Treatment Market Forecast
10.3.4 Southeast Asia Neuropathy Pain Treatment Market Forecast
10.3.5 India Neuropathy Pain Treatment Market Forecast
10.3.6 Australia Neuropathy Pain Treatment Market Forecast
10.4 Europe Neuropathy Pain Treatment Forecast by Country (2021-2026)
10.4.1 Germany Neuropathy Pain Treatment Market Forecast
10.4.2 France Neuropathy Pain Treatment Market Forecast
10.4.3 UK Neuropathy Pain Treatment Market Forecast
10.4.4 Italy Neuropathy Pain Treatment Market Forecast
10.4.5 Russia Neuropathy Pain Treatment Market Forecast
10.5 Middle East & Africa Neuropathy Pain Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Neuropathy Pain Treatment Market Forecast
10.5.2 South Africa Neuropathy Pain Treatment Market Forecast
10.5.3 Israel Neuropathy Pain Treatment Market Forecast
10.5.4 Turkey Neuropathy Pain Treatment Market Forecast
10.5.5 GCC Countries Neuropathy Pain Treatment Market Forecast
10.6 Global Neuropathy Pain Treatment Forecast by Type (2021-2026)
10.7 Global Neuropathy Pain Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuropathy Pain Treatment Product Offered
11.1.3 Pfizer Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Depomed
11.2.1 Depomed Company Information
11.2.2 Depomed Neuropathy Pain Treatment Product Offered
11.2.3 Depomed Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Depomed Main Business Overview
11.2.5 Depomed Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Neuropathy Pain Treatment Product Offered
11.3.3 Eli Lilly Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 Endo
11.4.1 Endo Company Information
11.4.2 Endo Neuropathy Pain Treatment Product Offered
11.4.3 Endo Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Endo Main Business Overview
11.4.5 Endo Latest Developments
11.5 Grünenthal Group
11.5.1 Grünenthal Group Company Information
11.5.2 Grünenthal Group Neuropathy Pain Treatment Product Offered
11.5.3 Grünenthal Group Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Grünenthal Group Main Business Overview
11.5.5 Grünenthal Group Latest Developments
11.6 Arbor Pharmaceuticals
11.6.1 Arbor Pharmaceuticals Company Information
11.6.2 Arbor Pharmaceuticals Neuropathy Pain Treatment Product Offered
11.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Arbor Pharmaceuticals Main Business Overview
11.6.5 Arbor Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Neuropathy Pain Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Calcium Channel Alpha 2-delta Ligands
Table 3. Major Players of Serotonin-norepinephrine Reuptake Inhibitors
Table 4. Major Players of Others
Table 5. Neuropathy Pain Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Neuropathy Pain Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
Table 8. Neuropathy Pain Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Neuropathy Pain Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)
Table 11. Global Neuropathy Pain Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Neuropathy Pain Treatment Revenue Market Share by Players (2019-2021E)
Table 13. Neuropathy Pain Treatment Key Players Head office and Products Offered
Table 14. Neuropathy Pain Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuropathy Pain Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Neuropathy Pain Treatment Market Size Market Share by Regions 2016-2021
Table 19. Americas Neuropathy Pain Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Neuropathy Pain Treatment Market Size Market Share by Country (2016-2021)
Table 21. Americas Neuropathy Pain Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
Table 23. Americas Neuropathy Pain Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)
Table 25. APAC Neuropathy Pain Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Neuropathy Pain Treatment Market Size Market Share by Region (2016-2021)
Table 27. APAC Neuropathy Pain Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
Table 29. APAC Neuropathy Pain Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)
Table 31. Europe Neuropathy Pain Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Neuropathy Pain Treatment Market Size Market Share by Country (2016-2021)
Table 33. Europe Neuropathy Pain Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
Table 35. Europe Neuropathy Pain Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Neuropathy Pain Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Neuropathy Pain Treatment
Table 44. Key Application and Potential Industries of Neuropathy Pain Treatment
Table 45. Key Challenges of Neuropathy Pain Treatment
Table 46. Key Trends of Neuropathy Pain Treatment
Table 47. Global Neuropathy Pain Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Neuropathy Pain Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Neuropathy Pain Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 53. Pfizer Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 54. Pfizer Neuropathy Pain Treatment Product Offered
Table 55. Pfizer Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Depomed Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 59. Depomed Neuropathy Pain Treatment Product Offered
Table 60. Depomed Main Business
Table 61. Depomed Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Depomed Latest Developments
Table 63. Eli Lilly Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 64. Eli Lilly Neuropathy Pain Treatment Product Offered
Table 65. Eli Lilly Main Business
Table 66. Eli Lilly Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Eli Lilly Latest Developments
Table 68. Endo Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 69. Endo Neuropathy Pain Treatment Product Offered
Table 70. Endo Main Business
Table 71. Endo Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Endo Latest Developments
Table 73. Grünenthal Group Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 74. Grünenthal Group Neuropathy Pain Treatment Product Offered
Table 75. Grünenthal Group Main Business
Table 76. Grünenthal Group Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Grünenthal Group Latest Developments
Table 78. Arbor Pharmaceuticals Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 79. Arbor Pharmaceuticals Neuropathy Pain Treatment Product Offered
Table 80. Arbor Pharmaceuticals Main Business
Table 81. Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Arbor Pharmaceuticals Latest Developments
List of Figures
Figure 1. Neuropathy Pain Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuropathy Pain Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Neuropathy Pain Treatment Market Size Market Share by Type in 2020
Figure 7. Neuropathy Pain Treatment in Retail Pharmacies
Figure 8. Global Neuropathy Pain Treatment Market: Retail Pharmacies (2016-2021) & ($ Millions)
Figure 9. Neuropathy Pain Treatment in Hospitals
Figure 10. Global Neuropathy Pain Treatment Market: Hospitals (2016-2021) & ($ Millions)
Figure 11. Neuropathy Pain Treatment in Others
Figure 12. Global Neuropathy Pain Treatment Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Neuropathy Pain Treatment Market Size Market Share by Application in 2020
Figure 14. Global Neuropathy Pain Treatment Revenue Market Share by Player in 2020
Figure 15. Global Neuropathy Pain Treatment Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Neuropathy Pain Treatment Market Size 2016-2021 ($ Millions)
Figure 17. APAC Neuropathy Pain Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Europe Neuropathy Pain Treatment Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Neuropathy Pain Treatment Market Size 2016-2021 ($ Millions)
Figure 20. Americas Neuropathy Pain Treatment Market Size Market Share by Country in 2020
Figure 21. Americas Neuropathy Pain Treatment Market Size Market Share by Type in 2020
Figure 22. Americas Neuropathy Pain Treatment Market Size Market Share by Application in 2020
Figure 23. United States Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Neuropathy Pain Treatment Market Size Market Share by Regions in 2020
Figure 27. APAC Neuropathy Pain Treatment Market Size Market Share by Type in 2020
Figure 28. APAC Neuropathy Pain Treatment Market Size Market Share by Application in 2020
Figure 29. China Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Neuropathy Pain Treatment Market Size Market Share by Country in 2020
Figure 36. Europe Neuropathy Pain Treatment Market Size Market Share by Type in 2020
Figure 37. Europe Neuropathy Pain Treatment Market Size Market Share by Application in 2020
Figure 38. Germany Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Application in 2020
Figure 46. Egypt Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Neuropathy Pain Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 52. APAC Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 53. Europe Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 55. United States Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Canada Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 59. China Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Japan Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Korea Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 63. India Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Australia Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Germany Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 66. France Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 67. UK Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Italy Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Russia Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Spain Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Israel Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Neuropathy Pain Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 신경 장애성 통증 치료 시장예측 2021년-2026년] (코드 : LPI-2201K02241) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 신경 장애성 통증 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 통증 펌프 시장예측 2021년-2026년
LPI-2201K02449 / LP Information / 2021년 12월 / 본 조사보고서는 통증 펌프의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pain Pumps will have significant change from previous year. By the most conservative estimates of global Pain Pumps market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 오피오이드 통증 패치 시장예측 2021년-2026년
LPI-2201K02120 / LP Information / 2021년 12월 / 본 조사보고서는 오피오이드 통증 패치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Opioid Pain Patche will have significant change from previous year. By the most conservative estimates of global Opioid Pain Patche market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 노안 치료 장치 시장예측 2021년-2026년
LPI-2201K02526 / LP Information / 2021년 12월 / 본 조사보고서는 노안 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Presbyopia Treatment Device will have significant change from previous year. By the most conservative estimates of global Presbyopia Treatment Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 과민성 방광 치료 시장예측 2021년-2026년
LPI-2201K02444 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in...

세계의 고콜레스테롤혈증 치료 시장예측 2021년-2026년
LPI-2201K00141 / LP Information / 2021년 12월 / 본 조사보고서는 고콜레스테롤혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hypercholesterolemia Treatment will have significant change from previous year. By the most conservative estimates of global Hypercholesterolemia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...